TFII.TO -1.7C 0.13MU -51.63CRWD 5.64PANW 6.15SNOW -4.82V -0.14MAL.TO -0.14
Pfizer Inc (PFE)

NYSE:PFE

Pfizer Inc (PFE)

25.01
+0.10 (0.40%)
as of Jul 31, 2026, 8:00:00 pm Market Open.
581 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
Investor Insights
star iconAug 2, 2026, 12:00 am

This summary was created by AI, based on 23 opinions in the last 12 months.

Pfizer Inc. (PFE) is currently facing challenges following its pandemic-driven peak during which it surged due to COVID-19 vaccine sales. Experts have pointed out a lack of earnings momentum and concerns over a patent cliff, as key drugs have come off patent and the company needs to innovate to develop new blockbuster drugs. Despite these challenges, many analysts emphasize the attractive dividend yield, which remains around 6-8%. The company is pivoting towards growth areas such as obesity and oncology, and while there's a general belief that PFE is under pressure, patience from investors could yield positive results. Several insights indicate that while it may not attract immediate growth, the company’s efforts in acquisitions and drug development could eventually pay off, given time.

consensus icon
Consensus
Hold
valuation icon
Valuation
Undervalued
review icon
Similar
MRK
PAST TOP PICK

Pfizer Inc(PFE)

Aug 18, 2003
(A top pick July 23/03.Down 4 «%.)Drug companies , stocks have dropped because they think of concerns on drug pricing.Longer-term demographically Phizer is very well-positioned.It represents great long-term value.
Photo of Laura WallaceLaura Wallace
Owned
Unlock Rating
$31.47

Stock price when the opinion was issued

$25.01

As of Jul 31, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Pfizer Inc(PFE)

Aug 12, 2003
Model price is around $29.Prefers Merk.Too expensive.
Photo of Brian Acker, CABrian Acker, CA
No
Unlock Rating
$32.87

Stock price when the opinion was issued

$25.01

As of Jul 31, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Aug 07, 2003
Likes this company.Valuation is more attractive than what it has been for some time.Generating growth, and very little risk in the stock.
Photo of John ZechnerJohn Zechner
Owned
Unlock Rating
$32.94

Stock price when the opinion was issued

$25.01

As of Jul 31, 2026. Market Open.

biotechnologypharmaceutical
HOLD

Pfizer Inc(PFE)

Jul 24, 2003
Good company. Pharmaceutical group is reasonably well priced. Compatition is coming into their core product line.
Photo of Ian AinsworthIan Ainsworth
Owned
Unlock Rating
$32.55

Stock price when the opinion was issued

$25.01

As of Jul 31, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Pfizer Inc(PFE)

Jul 23, 2003
15/25% earnings growth for the next 3/5 years. High quality.
Photo of Laura WallaceLaura Wallace
Owned
Unlock Rating
$32.93

Stock price when the opinion was issued

$25.01

As of Jul 31, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Pfizer Inc(PFE)

Jul 22, 2003
Ethical drug companies are not doing well at this time.
Photo of David BurrowsDavid Burrows
No
Unlock Rating
$32.43

Stock price when the opinion was issued

$25.01

As of Jul 31, 2026. Market Open.

biotechnologypharmaceutical
WEAK BUY

Pfizer Inc(PFE)

Jul 17, 2003
Has the deepest and broadest portfolio of any drug company. 20 drugs under development. Growth may be limited.
Photo of Brad WillockBrad Willock
Owned
Unlock Rating
$32.76

Stock price when the opinion was issued

$25.01

As of Jul 31, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Pfizer Inc(PFE)

Jul 15, 2003
Has a huge pipeline. PE is at a reasonable level. Good dividends and they are increasing.
Photo of Bob StodgellBob Stodgell
Owned
Unlock Rating
$33.86

Stock price when the opinion was issued

$25.01

As of Jul 31, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Pfizer Inc(PFE)

Jul 10, 2003
Fair market value is excellant. Investors like drug stocks.
Photo of Ross HealyRoss HealyUnlock Rating
$33.66

Stock price when the opinion was issued

$25.01

As of Jul 31, 2026. Market Open.

biotechnologypharmaceutical
HOLD

Pfizer Inc(PFE)

Jul 02, 2003
If you own it, don't let it make new lows on you. Trend is moving higher.
Photo of Bill CarriganBill CarriganUnlock Rating
$34.65

Stock price when the opinion was issued

$25.01

As of Jul 31, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Jun 19, 2003
All drug companies offer good value right now. Prefers Bristol Myers Squibb.
Photo of Ray SteeleRay SteeleUnlock Rating
$35.60

Stock price when the opinion was issued

$25.01

As of Jul 31, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Pfizer Inc(PFE)

Jun 13, 2003
US is making progress on a medicare drug plan. 17 X this years earnings and 16 X next. Great pipeline. The stock has underperformed.A lot of free cash flow.
Photo of Laura WallaceLaura WallaceUnlock Rating
$33.08

Stock price when the opinion was issued

$25.01

As of Jul 31, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Jun 11, 2003
US pharmaceuticals are looking cheaper than they have in some time.
Photo of John ZechnerJohn ZechnerUnlock Rating
$33.28

Stock price when the opinion was issued

$25.01

As of Jul 31, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Pfizer Inc(PFE)

Jun 05, 2003
(Was a top pick on Sept 18/02. Up 10%.) Still likes. Thought they would have been higher. Have the most new products coming on line.
Photo of Rob CallanderRob CallanderUnlock Rating
$32.75

Stock price when the opinion was issued

$25.01

As of Jul 31, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Pfizer Inc(PFE)

May 30, 2003
Has been stuck under a major technical resistance of $33/34. Could have a drop.
Photo of Ross HealyRoss HealyUnlock Rating
$31.02

Stock price when the opinion was issued

$25.01

As of Jul 31, 2026. Market Open.

biotechnologypharmaceutical
Showing 766 to 780 of 885 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EOG 3.18$148.69
SLB 0.68$49.59
SHEL 1.47$91.98
AAPL -24.52$308.91
AMZN 36.08$271.58

Today's Top Picks

TFII.TO -1.7$13.38
C 0.13$132.45
MU -51.63$823.03
CRWD 5.64$190.86
PANW 6.15$331.83

Popular Articles

Latest Sell Signals

AAPL -24.52$308.91
AAPL -24.52$308.91
AAPL -24.52$308.91
T.TO -1.7$13.38
CCA.TO -1.1$59.1

Most Recent Experts

Amy Raskin, CIO, Chevy Chase Trust

Amy Raskin, CIO, Chevy Chase Trust

Chevy Chase Trust

Stephanie Link, Chief investment strategist, Hightower

Stephanie Link, Chief investment strategist, Hightower

Hightower

Rob Sechan, Managing Partner, New Edge Capital

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Jim Lebenthal

Jim Lebenthal

Cerity Partners

Brianne Gardner

Brianne Gardner

Raymond James

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video

You may also like